Chordoma Spontaneous Regression After COVID-19

Chordomas are a low-to-intermediate-grade slow-growing subtype of sarcoma, but show propensity to grow and invade locally with recurrence and metastasis in 10–40% of cases. We describe the first case of spontaneous regression of a solid tumor (histologically and immunohistochemically proven chordoma...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis Fernando Moura da Silva Junior, Gyl Eanes Barros Silva, Marcos Adriano Garcia Campos, Antonio Augusto Lima Teixeira Júnior, Ramon Moura Santos, Orlando José dos Santos, Natalino Salgado Filho
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/17/1/10
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587378693242880
author Luis Fernando Moura da Silva Junior
Gyl Eanes Barros Silva
Marcos Adriano Garcia Campos
Antonio Augusto Lima Teixeira Júnior
Ramon Moura Santos
Orlando José dos Santos
Natalino Salgado Filho
author_facet Luis Fernando Moura da Silva Junior
Gyl Eanes Barros Silva
Marcos Adriano Garcia Campos
Antonio Augusto Lima Teixeira Júnior
Ramon Moura Santos
Orlando José dos Santos
Natalino Salgado Filho
author_sort Luis Fernando Moura da Silva Junior
collection DOAJ
description Chordomas are a low-to-intermediate-grade slow-growing subtype of sarcoma, but show propensity to grow and invade locally with recurrence and metastasis in 10–40% of cases. We describe the first case of spontaneous regression of a solid tumor (histologically and immunohistochemically proven chordoma) after COVID-19. A female patient with clival chordoma underwent occipitocervical fixation prior to tumor resection. In the early post-operative stage following the arthrodesis procedure, she was diagnosed with COVID-19. Six months after COVID-19, she finally came back for endoscopic endonasal resection of the tumor and pre-operative MRI surprisingly showed 98.9% regression of the tumor volume. Tumor resection was performed, and both histopathological and immunohistochemistry confirmed diagnosis of chordoma with positive brachyury levels. She showed improvement of right hemiparesis and left-sided tongue palsy. The tumor was comprised of tumor-infiltrating inflammatory cells. CD3 and CD68 were positive, suggesting the presence of T-lymphocytes and macrophages. CD20 and CD56 were negative, suggesting the absence of B-lymphocytes and NK-cells. The authors believe that the onset of COVID-19 exacerbated the patient’s immune response and improved anti-tumor immunity. It was concluded that T-cells, which are involved in the COVID-19 immune response and were found infiltrating the tumor, acted as a critical pathway to this event. Further studies are encouraged in order to gain a better understanding of the SARS-CoV-2–chordoma interaction.
format Article
id doaj-art-a9f37918da04456896f388c1975de05f
institution Kabale University
issn 1999-4915
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-a9f37918da04456896f388c1975de05f2025-01-24T13:52:14ZengMDPI AGViruses1999-49152024-12-011711010.3390/v17010010Chordoma Spontaneous Regression After COVID-19Luis Fernando Moura da Silva Junior0Gyl Eanes Barros Silva1Marcos Adriano Garcia Campos2Antonio Augusto Lima Teixeira Júnior3Ramon Moura Santos4Orlando José dos Santos5Natalino Salgado Filho6University Hospital of UFMA, Federal University of Maranhao, São Luís 65080-805, Maranhão, BrazilUniversity Hospital of UFMA, Federal University of Maranhao, São Luís 65080-805, Maranhão, BrazilDuke Global Health Institute, Duke University, Durham, NC 27710, USAPostgraduate Program in Genetics, Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirão Preto 14049-900, São Paulo, BrazilDr. Carlos Macieira Hospital, São Luís 65075-441, Maranhão, BrazilUniversity Hospital of UFMA, Federal University of Maranhao, São Luís 65080-805, Maranhão, BrazilUniversity Hospital of UFMA, Federal University of Maranhao, São Luís 65080-805, Maranhão, BrazilChordomas are a low-to-intermediate-grade slow-growing subtype of sarcoma, but show propensity to grow and invade locally with recurrence and metastasis in 10–40% of cases. We describe the first case of spontaneous regression of a solid tumor (histologically and immunohistochemically proven chordoma) after COVID-19. A female patient with clival chordoma underwent occipitocervical fixation prior to tumor resection. In the early post-operative stage following the arthrodesis procedure, she was diagnosed with COVID-19. Six months after COVID-19, she finally came back for endoscopic endonasal resection of the tumor and pre-operative MRI surprisingly showed 98.9% regression of the tumor volume. Tumor resection was performed, and both histopathological and immunohistochemistry confirmed diagnosis of chordoma with positive brachyury levels. She showed improvement of right hemiparesis and left-sided tongue palsy. The tumor was comprised of tumor-infiltrating inflammatory cells. CD3 and CD68 were positive, suggesting the presence of T-lymphocytes and macrophages. CD20 and CD56 were negative, suggesting the absence of B-lymphocytes and NK-cells. The authors believe that the onset of COVID-19 exacerbated the patient’s immune response and improved anti-tumor immunity. It was concluded that T-cells, which are involved in the COVID-19 immune response and were found infiltrating the tumor, acted as a critical pathway to this event. Further studies are encouraged in order to gain a better understanding of the SARS-CoV-2–chordoma interaction.https://www.mdpi.com/1999-4915/17/1/10spontaneous neoplastic regressioncoronavirus infectionnotochordsarcoma
spellingShingle Luis Fernando Moura da Silva Junior
Gyl Eanes Barros Silva
Marcos Adriano Garcia Campos
Antonio Augusto Lima Teixeira Júnior
Ramon Moura Santos
Orlando José dos Santos
Natalino Salgado Filho
Chordoma Spontaneous Regression After COVID-19
Viruses
spontaneous neoplastic regression
coronavirus infection
notochord
sarcoma
title Chordoma Spontaneous Regression After COVID-19
title_full Chordoma Spontaneous Regression After COVID-19
title_fullStr Chordoma Spontaneous Regression After COVID-19
title_full_unstemmed Chordoma Spontaneous Regression After COVID-19
title_short Chordoma Spontaneous Regression After COVID-19
title_sort chordoma spontaneous regression after covid 19
topic spontaneous neoplastic regression
coronavirus infection
notochord
sarcoma
url https://www.mdpi.com/1999-4915/17/1/10
work_keys_str_mv AT luisfernandomouradasilvajunior chordomaspontaneousregressionaftercovid19
AT gyleanesbarrossilva chordomaspontaneousregressionaftercovid19
AT marcosadrianogarciacampos chordomaspontaneousregressionaftercovid19
AT antonioaugustolimateixeirajunior chordomaspontaneousregressionaftercovid19
AT ramonmourasantos chordomaspontaneousregressionaftercovid19
AT orlandojosedossantos chordomaspontaneousregressionaftercovid19
AT natalinosalgadofilho chordomaspontaneousregressionaftercovid19